157 related articles for article (PubMed ID: 24740566)
1. SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.
Li H; Peng Y; Niu H; Wu B; Zhang Y; Zhang Y; Bai X; He P
Tumour Biol; 2014 Jul; 35(7):6949-54. PubMed ID: 24740566
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma.
Xie C; Fu L; Liu N; Li Q
Tumour Biol; 2014 Aug; 35(8):7685-91. PubMed ID: 24801907
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
Virchows Arch; 2015 Nov; 467(5):525-33. PubMed ID: 26293216
[TBL] [Abstract][Full Text] [Related]
4. SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro.
Chen F; Lu Z; Deng J; Han X; Bai J; Liu Q; Xi Y; Zheng J
Oncol Rep; 2014 Dec; 32(6):2533-40. PubMed ID: 25310386
[TBL] [Abstract][Full Text] [Related]
5. SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion.
Yi F; Ni W; Liu W; Pan X; Han X; Yang L; Kong X; Ma R; Chang R
Tumour Biol; 2013 Oct; 34(5):2849-55. PubMed ID: 23696027
[TBL] [Abstract][Full Text] [Related]
6. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.
Kanojia D; Garg M; Gupta S; Gupta A; Suri A
Am J Pathol; 2011 Mar; 178(3):1009-20. PubMed ID: 21356354
[TBL] [Abstract][Full Text] [Related]
7. SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer.
Luo S; Ren B; Zou G; Liu J; Chen W; Huang Y; Chen X; Fu Y
Oncol Rep; 2019 Apr; 41(4):2329-2336. PubMed ID: 30720101
[TBL] [Abstract][Full Text] [Related]
8. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
10. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
11. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer.
Garg M; Kanojia D; Suri S; Gupta S; Gupta A; Suri A
J Clin Endocrinol Metab; 2009 Nov; 94(11):4613-8. PubMed ID: 19820019
[TBL] [Abstract][Full Text] [Related]
12. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.
Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A
Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy.
Sinha A; Agarwal S; Parashar D; Verma A; Saini S; Jagadish N; Ansari AS; Lohiya NK; Suri A
J Exp Clin Cancer Res; 2013 Sep; 32(1):69. PubMed ID: 24330581
[TBL] [Abstract][Full Text] [Related]
14. Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma.
Kanojia D; Garg M; Saini S; Agarwal S; Parashar D; Jagadish N; Seth A; Bhatnagar A; Gupta A; Kumar R; Lohiya NK; Suri A
PLoS One; 2013; 8(12):e81348. PubMed ID: 24349057
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer.
Wang Y; Dong Q; Miao Y; Fu L; Lin X; Wang E
Lung Cancer; 2013 Aug; 81(2):266-72. PubMed ID: 23711689
[TBL] [Abstract][Full Text] [Related]
16. SPAG9 is overexpressed in osteosarcoma, and regulates cell proliferation and invasion through regulation of JunD.
Xiao C; Fu L; Yan C; Shou F; Liu Q; Li L; Cui S; Duan J; Jin G; Chen J; Bian Y; Wang X; Wang H
Oncol Lett; 2016 Oct; 12(4):2674-2679. PubMed ID: 27698841
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
18. Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.
Li H; Zhang Y; Zhang Y; Bai X; Peng Y; He P
Tumour Biol; 2014 Jun; 35(6):5771-6. PubMed ID: 24584698
[TBL] [Abstract][Full Text] [Related]
19. SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.
Xiao C; Li M; Huang Q; Si-Tu J
Am J Transl Res; 2019; 11(8):5249-5260. PubMed ID: 31497238
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer.
Burdelski C; Reiswich V; Hube-Magg C; Kluth M; Minner S; Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wittmer C; Huland H; Simon R; Schlomm T; Sauter G; Steurer S
Clin Cancer Res; 2015 Aug; 21(15):3471-9. PubMed ID: 25925890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
